TELA Bio’s management will be participating virtually in the H.C. Wainwright Annual
About
Investor Contact
332-895-3230
ir@telabio.com
Source:
2022 GlobeNewswire, Inc., source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.59 USD | -2.75% | +1.55% | -30.66% |
15/04 | TELA Bio, Inc. Announces U.S. Commercial Launch of Robotic-Compatible OviTex IHR | CI |
22/03 | Piper Sandler Adjusts Price Target on TELA Bio to $12 From $15, Maintains Overweight Rating | MT |
TELA Bio’s management will be participating virtually in the H.C. Wainwright Annual
About
Investor Contact
332-895-3230
ir@telabio.com
Source:
2022 GlobeNewswire, Inc., source
1st Jan change | Capi. | |
---|---|---|
-30.66% | 116M | |
-4.02% | 184B | |
-0.75% | 108B | |
-2.97% | 67.82B | |
+4.48% | 51.05B | |
+9.09% | 44.67B | |
+3.66% | 41.78B | |
+3.12% | 26.78B | |
+4.10% | 26.59B | |
+15.40% | 25.86B |